JP2013507116A5 - - Google Patents

Download PDF

Info

Publication number
JP2013507116A5
JP2013507116A5 JP2012532656A JP2012532656A JP2013507116A5 JP 2013507116 A5 JP2013507116 A5 JP 2013507116A5 JP 2012532656 A JP2012532656 A JP 2012532656A JP 2012532656 A JP2012532656 A JP 2012532656A JP 2013507116 A5 JP2013507116 A5 JP 2013507116A5
Authority
JP
Japan
Prior art keywords
polypeptide
nucleotide sequence
amino acid
vaccine composition
encoded
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012532656A
Other languages
English (en)
Japanese (ja)
Other versions
JP5963674B2 (ja
JP2013507116A (ja
Filing date
Publication date
Priority claimed from GBGB0917685.0A external-priority patent/GB0917685D0/en
Application filed filed Critical
Publication of JP2013507116A publication Critical patent/JP2013507116A/ja
Publication of JP2013507116A5 publication Critical patent/JP2013507116A5/ja
Application granted granted Critical
Publication of JP5963674B2 publication Critical patent/JP5963674B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012532656A 2009-10-09 2010-09-13 Asワクチンとして使用するための黄色ブドウ球菌divi1b Expired - Fee Related JP5963674B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0917685.0A GB0917685D0 (en) 2009-10-09 2009-10-09 Antigenic polypeptide
GB0917685.0 2009-10-09
PCT/GB2010/001722 WO2011042681A1 (en) 2009-10-09 2010-09-13 Staphylococcus aureus divi1b for use as vaccine

Publications (3)

Publication Number Publication Date
JP2013507116A JP2013507116A (ja) 2013-03-04
JP2013507116A5 true JP2013507116A5 (cg-RX-API-DMAC7.html) 2013-10-31
JP5963674B2 JP5963674B2 (ja) 2016-08-03

Family

ID=41402763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012532656A Expired - Fee Related JP5963674B2 (ja) 2009-10-09 2010-09-13 Asワクチンとして使用するための黄色ブドウ球菌divi1b

Country Status (8)

Country Link
US (2) US8691242B2 (cg-RX-API-DMAC7.html)
EP (1) EP2485757A1 (cg-RX-API-DMAC7.html)
JP (1) JP5963674B2 (cg-RX-API-DMAC7.html)
CN (1) CN102481353B (cg-RX-API-DMAC7.html)
AU (1) AU2010304915B2 (cg-RX-API-DMAC7.html)
CA (1) CA2775997A1 (cg-RX-API-DMAC7.html)
GB (1) GB0917685D0 (cg-RX-API-DMAC7.html)
WO (1) WO2011042681A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201206366D0 (en) * 2012-04-11 2012-05-23 Absynth Biologics Ltd Bacterial vaccine
GB201417214D0 (en) 2014-09-30 2014-11-12 Absynth Biologics Ltd Vaccine
CN116904356B (zh) * 2022-06-22 2026-06-23 浙江省农业科学院 模仿葡萄球菌hz01菌剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5955304A (en) * 1997-01-02 1999-09-21 Smithkline Beecham Corporation DivIB
US6022706A (en) * 1997-04-09 2000-02-08 Smithkline Beecham Corporation Div1b
AU2002306849A1 (en) * 2001-03-21 2002-10-08 Elitra Pharmaceuticals, Inc. Identification of essential genes in microorganisms
GB0107661D0 (en) 2001-03-27 2001-05-16 Chiron Spa Staphylococcus aureus
PT1551357E (pt) * 2002-09-13 2014-10-10 Novartis Vaccines & Diagnostic Vacina contra os estreptococos do grupo b
GB0409559D0 (en) * 2004-04-29 2004-06-02 Univ Sheffield Polypeptide
GB0505949D0 (en) * 2005-03-23 2005-04-27 Univ Sheffield Polypeptides

Similar Documents

Publication Publication Date Title
Rosini et al. Vaccines against antimicrobial resistance
Lipsitch et al. How can vaccines contribute to solving the antimicrobial resistance problem?
Fux et al. Can laboratory reference strains mirror ‘real-world’pathogenesis?
Holmes et al. What's new in the treatment of serious MRSA infection?
Munoz et al. Linezolid therapy for infective endocarditis
Mat Rahim et al. Facing the challenges of multidrug-resistant Acinetobacter baumannii: progress and prospects in the vaccine development
DK1372708T3 (da) Vaccine til transkutan immunisering mod rejsediarre
JP2011507500A5 (cg-RX-API-DMAC7.html)
Innamorati et al. The bacterial guide to designing a diversified gene portfolio
JP2013539751A5 (cg-RX-API-DMAC7.html)
JP2012513467A5 (cg-RX-API-DMAC7.html)
Maiden et al. Can we, should we, eradicate the meningococcus?
Fraser et al. Application of microbial genomic science to advanced therapeutics
Seong et al. Comparison of complete rpoB gene sequence typing and multi-locus sequence typing for phylogenetic analysis of Staphylococcus aureus
JP5963674B2 (ja) Asワクチンとして使用するための黄色ブドウ球菌divi1b
Perez et al. Are we closing in on an" elusive enemy"? The current status of our battle with Acinetobacter baumannii
WO2019033007A3 (en) Staphylococcus pseudintermedius virulence factor compositions
WO2009077744A3 (en) Vaccines for brucellosis
Hadi et al. Genome sequences of Mycobacterium tuberculosis biovar bovis strains Ravenel and 10-7428
US20160184421A1 (en) Immunotherapeutic targets against staphylococcus aureus
Batool et al. Draft genome sequences of lysostaphin-resistant (K07-204) and lysostaphin-susceptible (K07-561) staphylococcus aureus sequence type 72 strains isolated from patients in South Korea
Premkrishnan et al. Complete genome sequence of Staphylococcus haemolyticus type strain SGAir0252. Genome Announc 6: e00229-18
Farhab et al. Staphylococcus aureus and the Veterinary Medicine
Chopra et al. Emerging Antimicrobial Resistance in Staphylococcus and Spectrum of Oral Oxazolidinone Linezolid in Multidrug Resistant Staphylococcus in a Tertiary Care Hospital
AU2012241592B2 (en) Combination vaccine